Nexeon Medsystems Inc (NXNN) Financial Statements (2023 and Earlier)

Company Profile

Business Address 1910 PACIFIC AVENUE, SUITE 20000
DALLAS, TX 75201
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

Current Assets
Cash, cash equivalents, and short-term investments8842,040
Cash and cash equivalents8842,040
Inventory, net of allowances, customer advances and progress billings2,207 
Other current assets158128
Other undisclosed current assets804 
Total current assets:5,9302,168
Noncurrent Assets
Property, plant and equipment3,5701
Long-term investments and receivables 149
Long-term investments 149
Intangible assets, net (including goodwill) 8,747
Intangible assets, net (excluding goodwill) 8,747
Other undisclosed noncurrent assets10,852 
Total noncurrent assets:14,4218,897
TOTAL ASSETS:20,35111,065
Current Liabilities
Accounts payable and accrued liabilities3,079148
Accounts payable2,575112
Accrued liabilities50433
Interest and dividends payable 2
Due to related parties 0
Deferred tax liabilities174 
Other undisclosed current liabilities1,014 
Total current liabilities:5,134163
Noncurrent Liabilities
Liabilities, other than long-term debt 10
Due to related parties 10
Other undisclosed noncurrent liabilities3,349 
Total noncurrent liabilities:3,34910
Total liabilities:8,482173
Stockholders' equity
Stockholders' equity attributable to parent, including:11,86910,891
Common stock2822
Additional paid in capital15,4989,392
Accumulated other comprehensive income21 
Accumulated deficit(3,743)(1,592)
Other additional capital 3,070
Other undisclosed stockholders' equity attributable to parent66 
Total stockholders' equity:11,86910,891

Income Statement (P&L) ($ in thousands)

Cost of revenue
(Cost of Goods and Services Sold)
Gross profit:981 
Operating expenses(4,129)(1,412)
Other undisclosed operating loss(2,943) 
Operating loss:(6,091)(1,412)
Nonoperating expense
(Investment Income, Nonoperating)
Interest and debt expense(114)(6)
Loss from continuing operations before equity method investments, income taxes:(6,277)(1,591)
Other undisclosed income from continuing operations before income taxes4,100 
Loss from continuing operations before income taxes:(2,178)(1,591)
Income tax expense (636)
Net loss:(2,178)(2,227)
Other undisclosed net income attributable to parent 636
Net loss available to common stockholders, diluted:(2,178)(1,591)

Comprehensive Income ($ in thousands)

Net loss:(2,178)(2,227)
Comprehensive loss:(2,178)(2,227)
Other undisclosed comprehensive loss, net of tax, attributable to parent(16) 
Comprehensive loss, net of tax, attributable to parent:(2,193)(2,227)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios


Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: